Materials for pharmaceutical dosage forms: Molecular pharmaceutics and controlled release drug delivery aspects

International Journal of Molecular Sciences

Volumn 11, Issue 9, 2010, Pages 3298-3322

  Mansour, Heidi M ^a   Sohn, MinJi ^a   Al Ghananeem, Abeer ^a   DeLuca, Patrick P ^a  

^a University of Kentucky   (United States)

Author keywords

Biodegradable; Biomaterials; Copolymers; Manufacture; Microparticle; Nanoparticle; Particle engineering design; Pharmaceutical dosage forms; Polymers

Indexed keywords

ALGINIC ACID; ALLOPURINOL; CHITOSAN; COLLAGEN; COPOLYMER; DICLOFENAC; GELATIN; GENTAMICIN; HUMAN ALBUMIN; HYALURONIC ACID; IBUPROFEN; LEUPRORELIN; LEVONORGESTREL; LIDOCAINE; MACROGOL; MORPHINE; NIFEDIPINE; PACLITAXEL; POLOXAMER; POLYCAPROLACTONE; POLYGLACTIN; POLYLACTIC ACID; POLYVINYL ALCOHOL; POVIDONE; PROPRANOLOL; STARCH; TETRACAINE; TRAMADOL; UNINDEXED DRUG; VANCOMYCIN;

BIODEGRADABILITY; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DOSAGE FORM; DRUG MANUFACTURE; DRUG STABILITY; ENCAPSULATION; EVAPORATION; HYDROPHILICITY; NANOTECHNOLOGY; PHYSICAL CHEMISTRY; REVIEW; SPRAY DRYING; SUPERCRITICAL FLUID;

BIODEGRADABLE; BIOMATERIALS; COPOLYMERS; MANUFACTURE; MICROPARTICLE; NANOPARTICLE; PARTICLE ENGINEERING DESIGN; PHARMACEUTICAL DOSAGE FORMS; POLYMERS;

BIOCOMPATIBLE MATERIALS; BIODEGRADABLE PLASTICS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS;

EID: 77958493088     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms11093298     Document Type: Review

References (178)

1. Minko, T. Drug Delivery Systems-Controlled Drug Release. In Martns Physical Pharmacy and Pharmaceutical Sciences; Sinko, P.J., Ed.; Lippincott Williams & Wilkins: Baltimore, MD, USA, 2006; pp. 667-672.
2. Jantzen, G.M.; Robinson, J.R. Sustained- and Controlled-Release Drug Delivery Systems. In Modern Pharmaceutics; Banker, G.S., Rhodes, C.T., Eds.; Marcel Dekker, Inc: New York, NY, USA, 2002; pp. 501-528.
3. Longer, M.A.; Robinson, J.R. Sustained-Release Drug Delivery Systems. In Remington's Pharmaceutical Sciences; Gennaro, A.R., Ed.; Mack Publishing Company: Easton, PA, USA, 1990; pp. 1676-1693.
4. Ebube, N.K.; Hikal, A.H.; Wyandt, C.M.; Beer, D.C.; Miller, L.G.; Jones, A.B. Sustained release of acetaminophen from heterogeneous matrix tablets: Influence of polymer ratio, polymer loading, and co-active on drug release. Pharm. Dev. Technol. 1997, 2, 161-170.
5. Miyazaki, Y.; Yakou, S.;Takayama, K. Study on jelly fig extract as a potential hydrophilic matrix for controlled drug delivery. Int. J. Pharm. 2004, 287, 39-46.
6. Panyam, J.; Dali, M.M.; Sahoo, S.K.; Ma, W.; Chakravarthi, S.S.; Amidon, G.L.; Levy, R.J.; Labhasetwar, V. Polymer degradation and in vitro release of a model protein from poly (D,L-lactide-co-glycolide) nano- and microparticles. J. Control. Release 2003, 92, 173-187.
7. Wischke, C.; Schwendeman, S.P. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int. J. Pharm. 2008, 364, 298-327.
8. Fundueanu, G.; Constantin, M.; Dalpiaz, A.; Bortolotti, F.; Cortesi, R.; Ascenzi, P.; Menegatti, E. Preparation and characterization of starch/cyclodextrin bioadhesive microspheres as platform for nasal administration of Gabexate Mesylate (Foy) in allergic rhinitis treatment. Biomaterials 2004, 25, 159-170.
9. Peng, H.; Xiao, Y.; Mao, X.; Chen, L.; Crawford, R.; Whittaker, A.K. Amphiphilic triblock copolymers of methoxy-poly(ethylene glycol)-b-poly(L-lactide)-b-poly(L-lysine) for enhancement of osteoblast attachment and growth. Biomacromolecules 2009, 10, 95-104.
10. Na, D.H.; DeLuca, P.P. PEGylation of octreotide: I. Separation of positional isomers and stability against acylation by poly (D,L-lactide-co-glycolide). Pharm. Res. 2005, 22, 736-742.
11. Na, D.H.; Lee, J.E.; Jang, S.W.; Lee, K.C. Formation of acylated growth hormone-releasing peptide-6 by poly(lactide-co-glycolide) and its biological activity. AAPS Pharm. Sci. Tech. 2007, 8, 43.
12. Berkland, C.; King, M.; Cox, A.; Kim, K.; Pack, D.W. Precise control of PLG microsphere size provides enhanced control of drug release rate. J. Control. Release 2002, 82, 137-147.
13. Quaglia, F.; Ostacolo, L.; Nese, G.; De Rosa, G.; La Rotonda, M.I.; Palumbo, R.; Maglio, G. Microspheres made of poly (epsilon-caprolactone)-based amphiphilic copolymers: potential in sustained delivery of proteins. Macromol. Biosci. 2005, 5, 945-954.
14. Wei, H.; Zhang, X.Z.; Zhou, Y.; Cheng, S.X.; Zhuo, R.X. Self-assembled thermoresponsive micelles of poly (N-isopropylacrylamide-b-methyl methacrylate). Biomaterials 2006, 27, 2028-2034.
15. Kumar, N.; Ravikumar, M.N.; Domb, A.J. Biodegradable block copolymers. Adv. Drug Deliv. Rev. 2001, 53, 23-44.
16. Choi, S.; Baudys, M.; Kim, S.W. Control of blood glucose by novel GLP-1 delivery using biodegradable triblock copolymer of PLGA-PEG-PLGA in type 2 diabetic rats. Pharm. Res. 2004, 21, 827-831.
17. Jaraswekin, S.; Prakongpan, S.; Bodmeier, R. Effect of poly(lactide-co-glycolide) molecular weight on the release of dexamethasone sodium phosphate from microparticles. J. Microencapsul. 2007, 24, 117-128.
18. Wei, G.; Pettway, G.J.; McCauley, L.K.; Ma, P.X. The release profiles and bioactivity of parathyroid hormone from poly(lactic-co-glycolic acid) microspheres. Biomaterials 2004, 25, 345-352.
19. Tracy, M.A.; Ward, K.L.; Firouzabadian, L.; Wang, Y.; Dong, N.; Qian, R.; Zhang, Y. Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro. Biomaterials 1999, 20, 1057-1062.
20. Tsukada, Y.; Hara, K.; Bando, Y.; Huang, C.C.; Kousaka, Y.; Kawashima, Y.; Morishita, R.; Tsujimoto, H. Particle size control of poly(dl-lactide-co-glycolide) nanospheres for sterile applications. Int. J. Pharm. 2009, 370, 196-201.
21. Sinha, V.R.; Bansal, K.; Kaushik, R.; Kumria, R.; Trehan, A. Poly-epsilon-caprolactone microspheres and nanospheres: An overview. Int. J. Pharm. 2004, 278, 1-23.
22. Abuchowski, A.; McCoy, J.R.; Palczuk, N.C.; van Es, T.; Davis, F.F. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J. Biol. Chem. 1977, 252, 3582-3586.
23. Esposito, P.; Barbero, L.; Caccia, P.; Caliceti, P.; D'Antonio, M.; Piquet, G.; Veronese, F.M. PEGylation of growth hormone-releasing hormone (GRF) analogues. Adv. Drug Deliv. Rev. 2003, 55, 1279-1291.
24. Wu, Z.; Chen, H.; Liu, X.; Zhang, Y.; Li, D.; Huang, H. Protein Adsorption on Poly(N-vinylpyrrolidone)-Modified Silicon Surfaces Prepared by Surface-Initiated Atom Transfer Radical Polymerization. Langmuir 2009, 25, 2900-2906.
25. Mawad, D.; Poole-Warren, L.A.; Martens, P.; Koole, L.H.; Slots, T.L.; van Hooy-Corstjens, C.S. Synthesis and characterization of radiopaque iodine-containing degradable PVA hydrogels. Biomacromolecules 2008, 9, 263-268.
26. Fernandes, P.A.; Tzvetkov, G.; Fink, R.H.; Paradossi, G.; Fery, A. Quantitative analysis of scanning transmission X-ray microscopy images of gas-filled PVA-based microballoons. Langmuir 2008, 24, 13677-13682.
27. D'Souza, S.S.; DeLuca, P.P. Methods to assess in vitro drug release from injectable polymeric particulate systems. Pharm. Res. 2006, 23, 460-474.
28. Park, E.J.; Na, D.H.; Lee, K.C. In vitro release study of mono-PEGylated growth hormone-releasing peptide-6 from PLGA microspheres. Int. J. Pharm. 2007, 343, 281-283.
29. Sehra, S.; Dhake, A.S. Formulation and evaluation of sustained release microspheres of poly-lactide-co-glycolide containing tamoxifen citrate. J. Microencapsul. 2005, 22, 521-528.
30. Dailey, L.A.; Wittmar, M.; Kissel, T. The role of branched polyesters and their modifications in the development of modern drug delivery vehicles. J. Control. Release 2005, 101, 137-149.
31. Muschert, S.; Siepmann, F.; Leclercq, B.; Carlin, B.; Siepmann, J. Drug release mechanisms from ethylcellulose: PVA-PEG graft copolymer-coated pellets. Eur. J. Pharm. Biopharm. 2009, 72, 130-137.
32. Mumper, R.J.; Duguid, J.G.; Anwer, K.; Barron, M.K.; Nitta, H.; Rolland, A.P. Polyvinyl derivatives as novel interactive polymers for controlled gene delivery to muscle. Pharm. Res. 1996, 13, 701-709.
33. Hayama, M.; Yamamoto, K.; Kohori, F.; Uesaka, T.; Ueno, Y.; Sugaya, H.; Itagaki, I.; Sakai, K. Nanoscopic behavior of polyvinylpyrrolidone particles on polysulfone/polyvinylpyrrolidone film. Biomaterials 2004, 25, 1019-1028.
34. Kollidon® - Polyvinylpyrrolidone for the Pharmaceutical Industry; Buhler, V., Ed.; BASF: LUD, Germany, 1999.
35. Sahoo, J.; Murthy, P.N.; Biswal, S.M. Formulation of sustained-release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit RLPO or Kollidon SR. AAPS Pharm. Sci. Technol. 2009, 10, 27-33.
36. Natural-Based Polymers for Biomedical Applications; Reis, R.L., Neves, N.M., Mano, J.F., Gomes, M.E., Marques, A.P., Azevedo, H.S., Eds.; CRC Press-Woodhead Publishing Limited: Boca Raton, FL, USA, 2008.
37. Malafaya, P.B.; Silva, G.A.; Reis, R.L. Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv. Drug Deliv. Rev. 2007, 59, 207-233.
38. Bonacucina, G.; Di Martino, P.; Piombetti, M.; Colombo, A.; Roversi, F.; Palmieri, G.F. Effect of plasticizers on properties of pregelatinised starch acetate (Amprac 01) free films. Int. J. Pharm. 2006, 313, 72-77.
39. Ma, X.; Jian, R.; Chang, P.R.; Yu, J. Fabrication and characterization of citric acid-modified starch nanoparticles/plasticized-starch composites. Biomacromolecules 2008, 9, 3314-3320.
40. Coucke D.; Schotsaert M.; Libert C.; Pringels E.; Vervaet C.; Foreman P.; Saelens X.; Remon J.P. Spray-dried powders of starch and crosslinked poly(acrylic acid) as carriers for nasal delivery of inactivated influenza vaccine. Vaccine 2009, 27, 1279-1286.
41. Wei, L.; Cai, C.; Lin, J.; Chen, T. Dual-drug delivery system based on hydrogel/micelle composites. Biomaterials 2009, 30, 2606-2613.
42. Ozbas-Turan, S.; Akbuga, J.; Aral, C. Controlled release of interleukin-2 from chitosan microspheres. J. Pharm. Sci. 2002, 91, 1245-1251.
43. d'Ayala, G.G.; Malinconico, M.; Laurienzo, P. Marine derived polysaccharides for biomedical applications: chemical modification approaches. Molecules 2008, 13, 2069-2106.
44. Pajic-Lijakovic, I.; Plavsic, M.; Nedovic, V.; Bugarski, B. Investigation of Ca-alginate hydrogel rheological behaviour in conjunction with immobilized yeast cell growth dynamics. J. Microencapsul. 2007, 24, 420-429.
45. Liao, Y.H.; Jones, S.A.; Forbes, B.; Martin, G.P.; Brown, M.B. Hyaluronan: pharmaceutical characterization and drug delivery. Drug Delivery 2005, 12, 327-342.
46. Kang, J.Y.; Chung, C.W.; Sung, J.H.; Park, B.S.; Choi, J.Y.; Lee, S.J.; Choi, B.C.; Shim, C.K.; Chung, S.J.; Kim, D.D. Novel porous matrix of hyaluronic acid for the three-dimensional culture of chondrocytes. Int. J. Pharm. 2009, 369, 114-120.
47. Lin, W.; Coombes, A.G.; Davies, M.C.; Davis, S.S.; Illum, L. Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method. J. Drug. Target. 1993, 1, 237-243.
48. Weber, C.; Coester, C.; Kreuter, J.; Langer, K. Desolvation process and surface characterisation of protein nanoparticles. Int. J. Pharm. 2000, 194, 91-102.
49. Wang, G.; Siggers, K.; Zhang, S.; Jiang, H.; Xu, Z.; Zernicke, R.F.; Matyas, J.; Uludag, H. Preparation of BMP-2 containing bovine serum albumin (BSA) nanoparticles stabilized by polymer coating. Pharm. Res. 2008, 25, 2896-2909.
50. Friess, W. Collagen-biomaterial for drug delivery. Eur. J. Pharm. Biopharm. 1998, 45, 113-136.
51. Schoof, H.; Apel, J.; Heschel, I.; Rau, G. Control of pore structure and size in freeze-dried collagen sponges. J. Biomed. Mater. Res. 2001, 58, 352-357.
52. Sun, X.D.; Jeng, L.; Bolliet, C.; Olsen, B.R.; Spector, M. Non-viral endostatin plasmid transfection of mesenchymal stem cells via collagen scaffolds. Biomaterials 2009, 30, 1222-1231.
53. Young, S.; Wong, M.; Tabata, Y.; Mikos, A.G. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J. Control. Release 2005, 109, 256-274.
54. Adams, M.L.; Lavasanifar, A.; Kwon, G.S. Amphiphilic block copolymers for drug delivery. J. Pharm. Sci. 2003, 92, 1343-1355.
55. Kataoka, K.; Harada, A.; Nagasaki, Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv. Drug Deliv. Rev. 2001, 47, 113-131.
56. Otsuka, H.; Nagasaki, Y.; Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv. Drug Deliv. Rev.2003, 55, 403-419.
57. Lee, P.Y.; Li, Z.; Huang, L. Thermosensitive hydrogel as a Tgf-beta1 gene delivery vehicle enhances diabetic wound healing. Pharm. Res. 2003, 20, 1995-2000.
58. Frauke, P. K.; Breitenbach, A.; Zange-Volland, R.; Kissel, T. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,Llactic- co-glycolic acid). J. Control. Release 2001, 73, 7-20.
59. Jung, T.; Breitenbach, A.; Kissel, T. Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-coglycolide) s facilitate the preparation of small negatively charged biodegradable nanospheres. J. Control. Release 2000, 67, 157-169.
60. Jung, T.; Kamm, W.; Breitenbach, A.; Hungerer, K.D.; Hundt, E.; Kissel, T. Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice. Pharm. Res. 2001, 18, 352-360.
61. Jung, T.; Kamm, W.; Breitenbach, A.; Klebe, G.; Kissel, T. Loading of tetanus toxoid to biodegradable nanoparticles from branched poly(sulfobutyl-polyvinyl alcohol)-g-(lactide-coglycolide) nanoparticles by protein adsorption: a mechanistic study. Pharm. Res. 2002, 19, 1105-1113.
62. Batrakova, E.V.; Kabanov, A.V. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J. Control. Release 2008, 130, 98-106.
63. Kabanov, A.V.; Batrakova, E.V.; Alakhov, V.Y. Pluronic block copolymers for overcoming drug resistance in cancer. Adv. Drug Deliv. Rev. 2002, 54, 759-779.
64. Kabanov, A.V.; Batrakova, E.V.; Alakhov, V.Y. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J. Control. Release 2002, 82, 189-212.
65. Dhanikula, A.B.; Panchagnula, R. Localized paclitaxel delivery. Int. J. Pharm. 1999, 183, 85-100.
66. Wang, Y.; Yu, L.; Han, L.; Sha, X.; Fang, X. Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines. Int. J. Pharm. 2007, 337, 63-73.
67. Huh, K.M.; Lee, S.C.; Cho, Y.W.; Lee, J.; Jeong, J.H.; Park, K. Hydrotropic polymer micelle system for delivery of paclitaxel. J. Control. Release 2005, 101, 59-68.
68. Cheon, L.S.; Kim, C.; Chan, K.I.; Chung, H.; Young, J. S. Polymeric micelles of poly(2-ethyl-2- oxazoline)-block-poly(epsilon-caprolactone) copolymer as a carrier for paclitaxel. J. Control. Release 2003, 89, 437-446.
69. Le, G.D.; Gori, S.; Luo, L.; Lessard, D.; Smith, D.C.; Yessine, M.A.; Ranger, M.; Leroux, J.C. Poly(N-vinylpyrrolidone)-block-poly(D,L-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation. J. Control. Release 2004, 99, 83-101.
70. Xiong, X.B.; Uludag, H.; Lavasanifar, A. Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery. Biomaterials 2009, 30, 242-253.
71. Sun, T.M.; Du, J.Z.; Yan, L.F.; Mao, H.Q.; Wang, J. Self-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA delivery. Biomaterials 2008, 29, 4348-4355.
72. Gupte, A.; Ciftci, K. Formulation and characterization of Paclitaxel, 5-FU and Paclitaxel +5-FU microspheres. Int. J. Pharm. 2004, 276, 93-106.
73. Roullin, V.G.; Mege, M.; Lemaire, L.; Cueyssac, J.P.; Venier-Julienne, M.C.; Menei, P.; Gamelin, E.; Benoit, J.P. Influence of 5-fluorouracil-loaded microsphere formulation on efficient rat glioma radiosensitization. Pharm. Res. 2004, 21, 1558-1563.
74. Shuai, X.; Ai, H.; Nasongkla, N.; Kim, S.; Gao, J. Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J. Control. Release 2004, 98, 415-426.
75. Yadav, A.K.; Mishra, P.; Mishra, A.K.; Jain, S.; Agrawal, G.P. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Nanomedicine 2007, 3, 246-257.
76. Bae, Y.; Nishiyama, N.; Kataoka, K. In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments. Bioconjug. Chem. 2007, 18, 1131-1139.
77. Maeda, M.; Moriuchi, S.; Sano, A.; Yoshimine, T. New drug delivery system for water-soluble drugs using silicone and its usefulness for local treatment: application of GCV-silicone to GCV/HSV-tk gene therapy for brain tumor. J. Control. Release 2002, 84, 15-25.
78. Park, K.; Yang, J.H.; Choi, Y.; Lee, C.; Kim, S.Y.; Byun, Y. Chemoprevention of 4-NQO-induced oral carcinogenesis by co-administration of all-trans retinoic acid loaded microspheres and celecoxib. J. Control. Release 2005, 104, 167-179.
79. Sinha, V.R.; Bhinge, J.R.; Kumria, R.; Kumar, M. Development of pulsatile systems for targeted drug delivery of celecoxib for prophylaxis of colorectal cancer. Drug Delivery 2006, 13, 221-225.
80. D'Souza, R.; Mutalik, S.; Udupa, N. In Vitro and in Vivo preparation evaluations of bleomycin implants and microspheres Prepared with DL-poly (lactide-co-glycolide). Drug Dev. Ind. Pharm. 2006, 32, 175-184.
81. Shenoy, D.B.; D'Souza, R.J.; Udupa, N. Poly(DL-lactide-co-glycolide) microporous microsphere-based depot formulation of a peptide-like antineoplastic agent. J. Microencapsul. 2002, 19, 523-535.
82. Chen, J.; Cynkowski, T.; Guo, H.; Qin, K.; Cabral-Lilly, D.; Walters, K.; Ashton, P. Morphine pharmacokinetics following intra-articular administration of a novel sustained release opioid (CDS-PM-101) for the relief of post-operative orthopaedic pain. J. Control. Release 2005, 101, 359-360.
83. Morales, M.E.; Gallardo, L.V.; Calpena, A.C.; Domenech, J.; Ruiz, M.A. Comparative study of morphine diffusion from sustained release polymeric suspensions. J. Control. Release 2004, 95, 75-81.
84. Liu, F.I.; Kuo, J.H.; Sung, K.C.; Hu, O.Y. Biodegradable polymeric microspheres for nalbuphine prodrug controlled delivery: in vitro characterization and in vivo pharmacokinetic studies. Int. J. Pharm. 2003, 257, 23-31.
85. Tiwari, S.B.; Murthy, T.K.; Pai, M.R.; Mehta, P.R.; Chowdary, P.B. Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system. AAPS Pharm. Sci. Technol. 2003, 4, E31.
86. Dinarvand, R.; Alimorad, M.M.; Amanlou, M.; Akbari, H. In vitro release of clomipramine HCl and buprenorphine HCl from poly adipic anhydride (PAA) and poly trimethylene carbonate (PTMC) blends. J. Biomed. Mater. Res. Part A 2005, 75, 185-191.
87. Kleppner, S.R.; Patel, R.; McDonough, J.; Costantini, L.C. In vitro and in vivo characterization of a buprenorphine delivery system. J. Pharm. Pharmacol. 2006, 58, 295-302.
88. Seo, S.A.; Choi, H.S.; Khang, G.; Rhee, J.M.; Lee, H.B. A local delivery system for fentanyl based on biodegradable poly(L-lactide-co-glycolide) oligomer. Int. J. Pharm. 2002, 239, 93-101.
89. Seo, S.A.; Khang, G.; Rhee, J.M.; Kim, J.; Lee, H.B. Study on in vitro release patterns of fentanyl-loaded PLGA microspheres. J. Microencapsulaytion 2003, 20, 569-579.
90. Sendil, D.; Bonney, I.M.; Carr, D.B.; Lipkowski, A.W.; Wise, D.L.; Hasirci, V. Antinociceptive effects of hydromorphone, bupivacaine and biphalin released from PLGA polymer after intrathecal implantation in rats. Biomaterials 2003, 24, 1969-1976.
91. Lu, Y.; Zhang, G.; Sun, D.; Zhong, Y. Preparation and evaluation of biodegradable flubiprofen gelatin micro-spheres for intra-articular administration. J. Microencapsul. 2007, 24, 515-524.
92. Fernandez-Carballido, A.; Herrero-Vanrell, R.; Molina-Martinez, I.T.; Pastoriza, P. Sterilized ibuprofen-loaded poly(D,L-lactide-co-glycolide) microspheres for intra-articular administration: effect of gamma-irradiation and storage. J. Microencapsul. 2004, 21, 653-665.
93. Thakkar, H.; Sharma, R.K.; Mishra, A.K.; Chuttani, K.; Murthy, R.S. Celecoxib incorporated chitosan microspheres: in vitro and in vivo evaluation. J. Drug Targeting 2004, 12, 549-557.
94. Thakkar, H.; Sharma, R.K.; Mishra, A.K.; Chuttani, K.; Murthy, R.S. Efficacy of chitosan microspheres for controlled intra-articular delivery of celecoxib in inflamed joints. J. Pharm. Pharmacol. 2004, 56, 1091-1099.
95. Tuncay, M.; Calis, S.; Kas, H.S.; Ercan, M.T.; Peksoy, I.; Hincal, A.A. In vitro and in vivo evaluation of diclofenac sodium loaded albumin microspheres. J. Microencapsul. 2000, 17, 145-155.
96. Tuncay, M.; Calis, S.; Kas, H.S.; Ercan, M.T.; Peksoy, I.; Hincal, A.A. Diclofenac sodium incorporated PLGA (50:50) microspheres: formulation considerations and in vitro/in vivo evaluation. Int. J. Pharm. 2000, 195, 179-188.
97. La, S.B.; Okano, T.; Kataoka, K. Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(beta-benzyl L-aspartate) block copolymer micelles. J. Pharm. Sci. 1996, 85, 85-90.
98. Shin, I.G.; Kim, S.Y.; Lee, Y.M.; Cho, C.S.; Sung, Y.K. Methoxy poly(ethylene glycol)/epsiloncaprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization. J. Control. Release 1998, 51, 1-11.
99. Sendil-Keskin, D.; Altunay, H.; Wise, D.L.; Hasirci, V. In vivo pain relief effectiveness of an analgesic-anesthetic carrying biodegradable controlled release rod systems. J. Biomater. Sci., Polym. Ed. 2003, 14, 497-514.
100. Loughlin, R.G.; Tunney, M.M.; Donnelly, R.F.; Murphy, D.J.; Jenkins, M.; McCarron, P.A. Modulation of gel formation and drug-release characteristics of lidocaine-loaded poly(vinyl alcohol)-tetraborate hydrogel systems using scavenger polyol sugars. Eur. J. Pharm. Biopharm. 2008, 69, 1135-1146.
101. Moss, G.P.; Gullick, D.R.; Woolfson, A.D.; McCafferty, D.F. Mechanical characterization and drug permeation properties of tetracaine-loaded bioadhesive films for percutaneous local anesthesia. Drug Dev. Ind. Pharm. 2006, 32, 163-174.
102. Ratajczak-Enselme, M.; Estebe, J.P.; Dollo, G.; Chevanne, F.; Bec, D.; Malinovsky, J.M.; Ecoffey, C.; Le Corre, P. Epidural, intrathecal and plasma pharmacokinetic study of epidural ropivacaine in PLGA-microspheres in sheep model. Eur. J. Pharm. Biopharm. 2009, 72, 54-61.
103. Kiremitci, A.S.; Ciftci, A.; Ozalp, M.; Gumusderelioglu, M. Novel chlorhexidine releasing system developed from thermosensitive vinyl ether-based hydrogels. J. Biomed. Mater. Res. Part B 2007, 83, 609-614.
104. Bigucci, F.; Luppi, B.; Musenga, A.; Zecchi, V.; Cerchiara, T. Chitosan salts coated with stearic acid as colon-specific delivery systems for vancomycin. Drug Delivery 2008, 15, 289-293.
105. Nahar, M.; Mishra, D.; Dubey, V.; Jain, N.K. Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles. Nanomedicine 2008, 4, 252-261.
106. Jia, Y.; Joly, H.; Omri, A. Liposomes as a carrier for gentamicin delivery: development and evaluation of the physicochemical properties. Int. J. Pharm. 2008, 359, 254-263.
107. Lecaroz, C.; Gamazo, C.; Renedo, M.J.; Blanco-Prieto, M.J. Biodegradable micro- and nanoparticles as long-term delivery vehicles for gentamicin. J. Microencapsul. 2006, 23, 782-792.
108. Gillissen, M.; Steendam, R.; van der Laan, A.; Tijsma, E. Development of doxycycline-eluting delivery systems based on SynBiosys biodegradable multi-block copolymers. J. Control. Release 2006, 116, 90-92.
109. Mundargi, R.C.; Srirangarajan, S.; Agnihotri, S.A.; Patil, S.A.; Ravindra, S.; Setty, S.B.; Aminabhavi, T.M. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies. J. Control. Release 2007, 119, 59-68.
110. Giovagnoli, S.; Tsai, T.; DeLuca, P.P. Formulation and release behavior of doxycycline-alginate hydrogel microparticles embedded into pluronic F127 thermogels as a potential new vehicle for doxycycline intradermal sustained delivery. AAPS Pharm-Sci-Tech 2010, 11, 212-220.
111. Capan, Y.; Jiang, G.; Giovagnoli, S.; Na, K.H.; DeLuca, P.P. Preparation and characterization of poly(D,L-lactide-co-glycolide) microspheres for controlled release of human growth hormone. AAPS Pharm. Sci. Technol. 2003, 4, 28.
112. Chen, S.; Singh, J. Controlled release of growth hormone from thermosensitive triblock copolymer systems: In vitro and in vivo evaluation. Int. J. Pharm. 2008, 352, 58-65.
113. Na, D.H.; Lee, K.C.; DeLuca, P.P. PEGylation of octreotide: II. Effect of N-terminal mono-PEGylation on biological activity and pharmacokinetics. Pharm. Res. 2005, 22, 743-749.
114. Brache, V.; Faundes, A.; Alvarez, F.; Garcia, A.G. Transition from Norplant to Jadelle in a clinic with extensive experience providing contraceptive implants. Contraception 2006, 73, 364-367.
115. Dasaratha, D.M.; Vema, K.; Jayakumar, R.; Vamsadhara, C. Preparation and characterization of injectable microspheres of contraceptive hormones. Int. J. Pharm. 2003, 268, 23-29.
116. Dhanaraju, M.D.; Rajkannan, R.; Selvaraj, D.; Jayakumar, R.; Vamsadhara, C. Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study. Contraception 2006, 74, 148-156.
117. Pai, S.S.; Tilton, R.D.; Przybycien, T.M. Poly(ethylene glycol)-modified proteins: implications for poly(lactide-co-glycolide)-based microsphere delivery. AAPS J. 2009, 11, 88-98.
118. Wang, S.H.; Zhang, L.C.; Lin, F.; Sa, X.Y.; Zuo, J.B.; Shao, Q.X.; Chen, G.S.; Zeng, S. Controlled release of levonorgestrel from biodegradable poly(D,L-lactide-co-glycolide) microspheres: in vitro and in vivo studies. Int. J. Pharm. 2005, 301, 217-225.
119. Cheng, Y.H.; Illum, L.; Davis, S.S. Schizophrenia and drug delivery systems. J. Drug. Targeting 2000, 8, 107-117.
120. Hans, M.L.; Maxwell, C.; Ehrlichman, R.S.; Metzger, K.; Liang, Y.; Siegel, S.J.; Lowman, A.M. Evaluation of in vitro release and in vivo efficacy of mPEG-PLA-haloperidol conjugate micelle-like structures. J. Biomed. Mater. Res. Part B 2007, 83, 422-430.
121. Lu, Y.; Tang, X.; Cui, Y.; Zhang, Y.; Qin, F.; Lu, X. In vivo evaluation of risperidone-SAIB in situ system as a sustained release delivery system in rats. Eur. J. Pharm. Biopharm. 2008, 68, 422-429.
122. Lu, Y.; Yu, Y.; Tang, X. Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release. J. Pharm. Sci. 2007, 96, 3252-3262.
123. Agnihotri, S.A.; Aminabhavi, T.M. Controlled release of clozapine through chitosan microparticles prepared by a novel method. J. Control. Release 2004, 96, 245-259.
124. Nahata, T.; Saini, T.R. Optimization of formulation variables for the development of long acting microsphere based depot injection of olanzapine. J. Microencapsul. 2008, 25, 426-433.
125. Guthmann, C.; Lipp, R.; Wagner, T.; Kranz, H. Development of a novel osmotically driven drug delivery system for weakly basic drugs. Eur. J. Pharm. Biopharm. 2008, 69, 667-674.
126. McClelland, G.A.; Sutton, S.C.; Engle, K.; Zentner, G.M. The solubility-modulated osmotic pump: in vitro/in vivo release of diltiazem hydrochloride. Pharm. Res. 1991, 8, 88-92.
127. Mohammadi-Samani, S.; Adrangui, M.; Siahi-Shadbad, M.R.; Nokhodchi, A. An approach to controlled-release dosage form of propranolol hydrochloride. Drug Dev. Ind. Pharm. 2000, 26, 91-94.
128. Nokhodchi, A.; Momin, M.N.; Shokri, J.; Shahsavari, M.; Rashidi, P.A. Factors affecting the release of nifedipine from a swellable elementary osmotic pump. Drug Delivery 2008, 15, 43-48.
129. Wang, X.; Nie, S.F.; Li, W.; Luan, L.; Pan, W. Studies on bi-layer osmotic pump tablets of water-insoluble allopurinol with large dose: in vitro and in vivo. Drug Dev. Ind. Pharm. 2007, 33, 1024-1029.
130. He, L.; Gong, T.; Zhao, D.; Zhang, Z.R.; Li, L. A novel controlled porosity osmotic pump system for sodium ferulate. Pharmazie 2006, 61, 1022-1027.
131. Rani, M.; Mishra, B. Comparative in vitro and in vivo evaluation of matrix, osmotic matrix, and osmotic pump tablets for controlled delivery of diclofenac sodium. AAPS Pharm. Sci. Technol. 2004, 5, 71.
132. Makhija, S.N.; Vavia, P.R. Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine. I. Cellulose acetate as a semipermeable membrane. J. Control. Release 2003, 89, 5-18.
133. Kang, F.; Singh, J. Effect of additives on the release of a model protein from PLGA microspheres. AAPS Pharm-Sci-Tech 2001, 2, 30.
134. Blanco, D.; Alonso, M.J. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. Eur. J. Pharm. Biopharm. 1998, 45, 285-294.
135. Sandor, M.; Enscore, D.; Weston, P.; Mathiowitz, E. Effect of protein molecular weight on release from micron-sized PLGA microspheres. J. Control. Release 2001, 76, 297-311.
136. Misra, S.K.; Ansari, T.I.; Valappil, S.P.; Mohn, D.; Philip, S.E.; Stark, W.J.; Roy, I.; Knowles, J.C.; Salih, V.; Boccaccini, A.R. Poly(3-hydroxybutyrate) multifunctional composite scaffolds for tissue engineering applications. Biomaterials 2010, 31, 2806-2815.
137. Francis, L.; Meng, D.; Knowles, J.C.; Roy, I.; Boccaccini, A.R. Multi-functional P(3HB) microsphere/45S5 Bioglass-based composite scaffolds for bone tissue engineering. Acta Biomater. 2010, 6, 2773-2786.
138. Mourino, V.; Boccaccini, A.R. Bone tissue engineering therapeutics: Controlled drug delivery in three-dimensional scaffolds. J. R. Soc. Interface 2009, 7, 209-227.
139. Dani, B.A.; Raiche, A.T.; Puleo, D.A.; DeLuca, P.P. A study of the antiresorptive activity of salmon calcitonin microspheres using cultured osteoclastic cells. AAPS Pharm. Sci. Technol. 2002, 3, E21.
140. Raiche, A.T.; Puleo, D.A. Association polymers for modulated release of bioactive proteins. IEEE Eng. Med. Biol. Mag. 2003, 22, 35-41.
141. Jeon, J.H.; Thomas, M.V.; Puleo, D.A. Bioerodible devices for intermittent release of simvastatin acid. Int. J. Pharm. 2007, 340, 6-12.
142. Jeon, J.H.; Piepgrass, W.T.; Lin, Y.L.; Thomas, M.V.; Puleo, D.A. Localized intermittent delivery of simvastatin hydroxyacid stimulates bone formation in rats. J. Periodontol 2008, 79, 1457-1464.
143. Jeon, J.H.; Puleo, D.A. Alternating release of different bioactive molecules from a complexation polymer system. Biomaterials 2008, 29, 3591-3598.
144. Mansour, H.M.; Rhee, Y.S.; Wu, X. Nanomedicine in Pulmonary Delivery. Int. J. Nanomed. 2009, 4, 299-319.
145. Barichello, J.M.; Morishita, M.; Takayama, K.; Nagai, T. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev. Ind. Pharm. 1999, 25, 471-476.
146. Kumar, P.S.; Ramakrishna, S.; Saini, T.R.; Diwan, P.V. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles. Pharmazie 2006, 61, 613-617.
147. Hafeli, U.O. Magnetically modulated therapeutic systems. Int. J. Pharm. 2004, 277, 19-24.
148. Cheng, J.; Teply, B.A.; Jeong, S.Y.; Yim, C.H.; Ho, D.; Sherifi, I.; Jon, S.; Farokhzad, O.C.; Khademhosseini, A.; Langer, R.S. Magnetically responsive polymeric microparticles for oral delivery of protein drugs. Pharm. Res. 2006, 23, 557-564.
149. Mundargi, R.C.; Babu, V.R.; Rangaswamy, V.; Patel, P.; Aminabhavi, T.M. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. J. Control. Release 2008, 125, 193-209.
150. Florence, A.T. Pharmaceutical Aspects of Nanotechnology. In Modern Pharmaceutics: Volume 2-Applications and Advances; Florence, A.T., Siepmann, J., Eds.; Informa Healthcare: New York, NY, USA, 2009; pp. 453-492.
151. Hickey, A.J.; Mansour, H.M. Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols. In Modified-Release Drug Delivery Technology; Rathbone, M.J., Hadgraft, J., Roberts, M.S., Lane, M.E., Eds.; Informa Healthcare: New York, NY, USA, 2008; pp. 573-602.
152. Supercritical Fluid Technology for Drug Product Development; York, P., Kompella, U.B., Shekunov, B.Y., Eds.; Informa Healthcare: New York, NY, USA, 2004.
153. Williams, J.R.; Clifford, A.A.; al-Saidi, S.H. Supercritical fluids and their applications in biotechnology and related areas. Mol. Biotechnol. 2002, 22, 263-286.
154. Mishima, K. Biodegradable particle formation for drug and gene delivery using supercritical fluid and dense gas. Adv. Drug Deliv. Rev. 2008, 60, 411-432.
155. Lee, L.Y.; Wang, C.H.; Smith, K.A. Supercritical antisolvent production of biodegradable microand nanoparticles for controlled delivery of paclitaxel. J. Control. Release 2008, 125, 96-106.
156. Li, W.; Zhang, J.; Zhang, C.; Feng, X.; Han, B.; Yang, G. Synthesis of alpha-chymotrypsin/polymer composites by a reverse micelle/gas antisolvent method. Colloids Surf. B. Biointerfaces 2007, 59, 11-15.
157. Steckel, H.; Pichert, L.; Muller, B.W. Influence of process parameters in the ASES process on particle properties of budesonide for pulmonary delivery. Eur. J. Pharm. Biopharm. 2004, 57, 507-512.
158. Bleich, J.; Muller, B.W. Production of drug loaded microparticles by the use of supercritical gases with the aerosol solvent extraction system (ASES) process. J. Microencapsul. 1996, 13, 131-139.
159. Palakodaty, S.; York, P.; Pritchard, J. Supercritical fluid processing of materials from aqueous solutions: the application of SEDS to lactose as a model substance. Pharm. Res. 1998, 15, 1835-1843.
160. Chow, A.H.; Tong, H.H.; Chattopadhyay, P.; Shekunov, B.Y. Particle engineering for pulmonary drug delivery. Pharm. Res. 2007, 24, 411-437.
161. Dunbar, C.A.; Concessio, N.M.; Hickey, A.J. Evaluation of atomizer performance in production of respirable spray-dried particles. Pharm. Dev. Technol. 1998, 3, 433-441.
162. Elversson, J.; Millqvist-Fureby, A.; Alderborn, G.; Elofsson, U. Droplet and particle size relationship and shell thickness of inhalable lactose particles during spray drying. J. Pharm. Sci. 2003, 92, 900-910.
163. Elversson, J.; Millqvist-Fureby, A. Particle size and density in spray drying-effects of carbohydrate properties. J. Pharm. Sci. 2005, 94, 2049-2060.
164. Gilani, K.; Najafabadi, A.R.; Barghi, M.; Rafiee-Tehrani, M. The effect of water to ethanol feed ratio on physical properties and aerosolization behavior of spray dried cromolyn sodium particles. J. Pharm. Sci. 2005, 94, 1048-1059.
165. Maa, Y.F.; Costantino, H.R.; Nguyen, P.A.; Hsu, C.C. The effect of operating and formulation variables on the morphology of spray-dried protein particles. Pharm. Dev. Technol. 1997, 2, 213-223.
166. Rogers, T.L.; Johnston, K.P.; Williams, R.O. Solution-based particle formation of pharmaceutical powders by supercritical or compressed fluid CO2 and cryogenic spray-freezing technologies. Drug Dev. Ind. Pharm. 2001, 27, 1003-1015.
167. Maa, Y.F.; Prestrelski, S.J. Biopharmaceutical powders: particle formation and formulation considerations. Curr. Pharm. Biotechnol. 2000, 1, 283-302.
168. Costantino, H.R.; Firouzabadian, L.; Hogeland, K.; Wu, C.; Beganski, C.; Carrasquillo, K.G.;Cordova, M.; Griebenow, K.; Zale, S.E.; Tracy, M.A. Protein spray-freeze drying. Effect of atomization conditions on particle size and stability. Pharm. Res. 2000, 17, 1374-1383.
169. Yu, Z.; Rogers, T.L.; Hu, J.; Johnston, K.P.; Williams, R.O. Preparation and characterization of microparticles containing peptide produced by a novel process: spray freezing into liquid. Eur. J. Pharm. Biopharm. 2002, 54, 221-228.
170. Hu, J.; Johnston, K.P.; Williams, R.O. Stable amorphous danazol nanostructured powders with rapid dissolution rates produced by spray freezing into liquid. Drug Dev. Ind. Pharm. 2004, 30, 695-704.
171. D'Souza, S.S.; Faraj, J.A.; DeLuca, P.P. A model-dependent approach to correlate accelerated with real-time release from biodegradable microspheres. AAPS Pharm-Sci-Tech 2005, 6, E553-564.
172. D'Souza, S.S.; Selmin, F.; Murty, S.B.; Qiu, W.; Thanoo, B.C.; DeLuca, P.P. Assessment of fertility in male rats after extended chemical castration with a GnRH antagonist. AAPS J. 2004, 6, 94-99.
173. Kane, J.M.; Eerdekens, M.; Lindenmayer, J.P.; Keith, S.J.; Lesem, M.; Karcher, K. Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic. Am. J. Psychiatry 2003, 160, 1125-1132.
174. Kostanski, J.W.; Thanoo, B.C.; DeLuca, P.P. Preparation, characterization, and in vitro evaluation of 1- and 4-month controlled release orntide PLA and PLGA microspheres. Pharm. Dev. Technol. 2000, 5, 585-596.
175. Okada, H.; Doken, Y.; Ogawa, Y.; Toguchi, H. Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers. Pharm. Res. 1994, 11, 1143-1147.
176. Woo, B.H.; Na, K.H.; Dani, B.A.; Jiang, G.; Thanoo, B.C.; DeLuca, P.P. In vitro characterization and in vivo testosterone suppression of 6-month release poly (D,L-lactide) leuprolide microspheres. Pharm. Res. 2002, 19, 546-550.
177. Matsumura, Y. Poly (amino acid) micelle nanocarriers in preclinical and clinical studies. Adv. Drug Deliv. Rev. 2008, 60, 899-914.
178. Kanagale, P.; Patel, V.; Venkatesan, N.; Jain, M.; Patel, P.; Misra, A. Pharmaceutical development of solid dispersion based osmotic drug delivery system for nifedipine. Curr. Drug Deliv. 2008, 5, 306-311.